| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.62 | 0.003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |